Published in AIDS Weekly, April 12th, 2004
The proposed coformulation combines Viread and Emtriva in a single pill dosed once daily, to be taken in combination with other antiretrovirals for the treatment of HIV.
The company also announced the submission of its marketing authorization application (MAA) for the fixed dose coformulation to the European Agency for the Evaluation of Medicinal Products (EMEA)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.